Yessotoxin is a marine phycotoxin that induces motor alterations in mice after intraperitoneal injection. In primary cortical neurons, yessotoxin treatment induced a caspase-independent cell death with an IC 50 of 4.27 nM. This neurotoxicity was enhanced by 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid and partially blocked by amiloride. Unlike previous studies, yessotoxin did not increase cyclic adenosine monophosphate levels or produce any change in phosphodiesterase 4 steady state expression in triple transgenic neurons. Since phosphodiesterases (PDEs) are engaged in learning and memory, we studied the in vitro effect of the toxin against Alzheimer's disease hallmarks and observed that pretreatment of cortical 3xTg-AD neurons with a low nanomolar concentration of yessotoxin showed a decrease expression of hyperphosphorylated tau isoforms and intracellular accumulation of amyloid-beta. These effects were accompanied with an increase in the level of the inactive isoform of the glycogen synthase kinase 3 and also by a translocation of protein kinase C from cytosol to membrane, pointing to its activation. In fact, inhibition of protein kinase C with GF109203X blocked the effect of yessotoxin over tau protein. The data presented here shows that 1 nM yessotoxin activates protein kinase C with beneficial effects over the main Alzheimer's disease hallmarks, tau and Aβ, in a cellular model obtained from 3xTg-AD fetuses. KEYWORDS: Marine toxin, yessotoxin, Alzheimer's disease, protein kinase C Y essotoxin (YTX) is a marine phycotoxin with more than 40 analogues isolated for the first time in Japanese waters. It is produced by different dinoflagellates, among them, Protoceratium reticulatum and Lingulodinium polyedrum.
1−3Originally, the toxin was included with the okadaic acid (OA) in the group of diarrheic shellfish poisoning (DSP) toxins, because they used to appear together during toxic episodes. Later, it was separated in its own group, due to different biological origin and different in vivo effects. 4 One of the main differences with OA is that YTX shows no inhibition of protein phosphatase 2A (PP2A). 5 Recently, it has been observed that, in fact, YTX and OA show an immunoregulatory effect over lymphocytes, although through protein kinase C (PKC) mediated mechanisms in the case of YTX and through PP2A mechanisms in the case of OA.
6PKC is widely expressed in neurons, and it is implicated in neuroprotection, synaptic function, and plasticity. This turns it into an important molecule in learning and memory, and its signaling disruption causes impairment in these processes.
7−9Moreover, reduced PKC levels were found in samples from patients with Alzheimer's disease (AD).10 Several pieces of evidence indicate that amyloid beta (Aβ) peptide can reduce PKC levels and also block the activation and normal function of the enzyme.11 All these findings indicate that PKC activators may constitute an interesting target for AD related pathology, as PKC isoforms are involved in memory processing and the enzyme c...